Form 4 for RANI Rani Therapeutics Holdings, Inc.
Accepted 2022-02-07 00:00:00 ET · period of report 2022-02-03 · accession 0001209191-22-007638 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-02-07 | 2022-02-03 | RANI | Nanavaty Maulik | Dir | J - Other | $0.00 | +11.0K | 11.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-03 | J | A | 11,017 | $0.00 | 11,017 | I By spouse | — | — |